Thyroid Hormone Receptor β Knockdown Reduces Suppression of Progestins by Activating the mTOR Pathway in Endometrial Cancer Cells

Progestin resistance is a major obstacle to conservative therapy in patients with endometrial cancer (EC) and endometrial atypical hyperplasia (EAH). However, the related inducing factor is yet unclear. In this study, thyroid hormone and its receptor α (TRα) and β (TRβ) of patients were assayed. THR...

Descripción completa

Detalles Bibliográficos
Autores principales: Ren, Bingtao, Zhou, Jieyun, Hu, Yingyi, Zhong, Ruihua, Lv, Qiaoying, Xie, Shuwu, Li, Guoting, Yang, Bingyi, Chen, Xiaojun, Zhu, Yan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9604373/
https://www.ncbi.nlm.nih.gov/pubmed/36293372
http://dx.doi.org/10.3390/ijms232012517

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9604373/
https://www.ncbi.nlm.nih.gov/pubmed/36293372
http://dx.doi.org/10.3390/ijms232012517

Ejemplares similares